SCHEDULE 13D

Company

SUPERNUS PHARMACEUTICALS, INC.

Filed

July 7, 2014

Accession Number

0000902664-14-003036

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →